Delivery Order SPE2DB24D3013-SPE2DB25FFNQP
- Not listed
- The Defense Logistics Agency awarded a $2,412.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, with an ultimate completion date of July 25, 2025, was awarded on July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a small-value transaction within...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,249.60 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injector units. This competitive award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price contract with no set-aside designation. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Sumatriptan 6 mg/0.5 ml autoinjectors, a medication used to treat migraine headaches. The contract has a firm fixed price of $3,778.81 and a period of performance through May 2, 2025. This order is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,086.19 fixed-price delivery order is for the supply of Sumatriptan 6 mg/0.5 ml autoinjectors, a specialty medication used to treat migraines. The contract has a completion date of March 27, 2025 and does not include any set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Sumatriptan 6 mg/0.5 ml autoinjectors, a medication used to treat migraines. The delivery order has a ceiling value of $6,064.16 and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,350 units of Sumatriptan 6 mg/0.5 ml autoinjectors. The firm-fixed-price contract has a ceiling value of $11,007.96 and an ultimate completion date of August 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical migraine medication autoinjectors to support military treatment facilities and other federal healthcare providers. This...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,927.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Sumatriptan 6 mg/0.5 mL autoinjectors. The contract has an ultimate completion date of November 25, 2024 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,648.91 firm fixed-price contract is for the supply of Sumatriptan 6 mg/0.5 ml autoinjector medication. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Sumatriptan 6 mg/0.5 mL autoinjectors. The award is for a firm fixed price contract with a ceiling value of $5,016.19 and a period of performance through May 2, 2025. This order is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Sumatriptan 6 mg/0.5 ml autoinjectors. The contract has a ceiling value of $2,266.77 and a completion date of July 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the primary vehicle for...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFNQPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,137.07 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, awarded on July 23, 2025, with a completion date of July 24, 2025, utilizes firm fixed pricing with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical support vehicle valued through December 2026 that enables the company to supply medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through competitive awards, supplying specialty medications, vaccines, medical devices, and generic drugs across multiple therapeutic domains. This delivery order for Sumatriptan, a migraine treatment, represents a routine fulfillment under the company's broad pharmaceutical supply agreement with the DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/23/25 |